'Fringe' Production Delay Extended as Star John Noble Treated for Sleep Disorder
Filming was expected to resume early next week, but the shutdown has been extended until early August.
Production on Fox's sci-fi drama Fringe has been shut down for two weeks due to the illness of star John Noble.
A source with knowledge of the situation tells The Hollywood Reporter that the 63-year-old Noble, who plays scientist Walter Bishop on the show, is being treated for a sleep disorder. Noble's illness effectively shut down filming on the fifth and final season on Tuesday -- just one day after he was expected to appear on the Television Critics Assn. press tour panel with Anna Torv, Joshua Jackson, Lance Reddick and showrunner J.H. Wyman.
The delay was initially said to be only three days, but sources now say it will be extended to nine shooting days, until about Aug. 7.
Noble's absence was addressed during the Fringe session at the Television Critics Association gathering on Monday, with Wyman telling reporters that the actor was "under the weather."
Filming on the season five premiere began last Wednesday in Vancouver and continued Thursday and Friday. Production on the series was paused Monday so cast members could attend TCA.
Separately, on Tuesday a source confirmed to THR that production had been impacted by co-star Jasika Nicole's car accident, in addition to multiple illnesses in the cast.
The extended delay is not expected to impact the series' Sept. 28 premiere date.
The news comes after castmates and Wyman publicly lauded Noble, who appeared at Comic-Con on July 15, for his work on Fringe and discussed his Emmy snub for his complicated performance on the sci-fi series.
- Prince Takes Over the 'Arsenio Hall Show,' Debuts New Funky Song
- A Train, a Trestle and 60 Seconds to Escape: How 'Midnight Rider' Victim Sarah Jones Lost Her Life
- 'Divergent' Star Shailene Woodley: The Next Jennifer Lawrence?
- 'Noah' Banned in Several Middle Eastern Countries
- Lindsay Lohan's OWN Series Gets First Official Trailer (Video)
- MOST SHARED
- MOST POPULAR